Globe Life (NYSE:GL) Issues Earnings Results

Globe Life (NYSE:GL) announced its quarterly earnings results on Wednesday. The company reported $3.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.49 by ($0.06), FiscalAI reports. Globe Life had a return on equity of 21.30% and a net margin of 19.37%.The business had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.56 billion. Globe Life updated its FY 2026 guidance to 15.400-15.90 EPS.

Globe Life Trading Up 0.3%

Shares of Globe Life stock traded up $0.44 on Wednesday, reaching $151.36. 568,844 shares of the company were exchanged, compared to its average volume of 500,687. The stock has a fifty day moving average price of $143.17 and a 200-day moving average price of $139.20. The firm has a market capitalization of $11.87 billion, a price-to-earnings ratio of 10.75 and a beta of 0.47. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.39. Globe Life has a fifty-two week low of $111.13 and a fifty-two week high of $152.80.

Globe Life Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Stockholders of record on Friday, April 3rd will be given a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.9%. This is a boost from Globe Life’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Thursday, April 2nd. Globe Life’s payout ratio is presently 9.38%.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on GL shares. Keefe, Bruyette & Woods reissued a “moderate buy” rating and issued a $168.00 price objective on shares of Globe Life in a research note on Thursday, March 26th. Evercore set a $157.00 price objective on Globe Life in a research note on Wednesday, February 18th. Wells Fargo & Company boosted their price objective on Globe Life from $171.00 to $172.00 and gave the stock an “overweight” rating in a research note on Friday, April 10th. Truist Financial boosted their price objective on Globe Life from $158.00 to $180.00 and gave the stock a “buy” rating in a research note on Friday, February 6th. Finally, Piper Sandler raised Globe Life to a “strong-buy” rating in a research note on Thursday, April 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $172.11.

Insider Activity at Globe Life

In other news, CMO Jennifer Allison Haworth sold 10,000 shares of the business’s stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $143.14, for a total transaction of $1,431,400.00. Following the sale, the chief marketing officer directly owned 17,479 shares of the company’s stock, valued at $2,501,944.06. The trade was a 36.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Frank M. Svoboda sold 12,500 shares of the business’s stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total value of $1,809,750.00. Following the sale, the chief executive officer directly owned 35,868 shares in the company, valued at $5,192,969.04. This trade represents a 25.84% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 82,807 shares of company stock valued at $12,041,286 over the last ninety days. Company insiders own 2.11% of the company’s stock.

Institutional Investors Weigh In On Globe Life

A number of institutional investors and hedge funds have recently modified their holdings of GL. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Globe Life by 6.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock worth $1,237,000 after purchasing an additional 607 shares during the period. NewEdge Advisors LLC grew its holdings in shares of Globe Life by 368.1% during the first quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock valued at $897,000 after buying an additional 5,352 shares in the last quarter. Goldman Sachs Group Inc. grew its holdings in shares of Globe Life by 11.5% during the first quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company’s stock valued at $74,161,000 after buying an additional 58,163 shares in the last quarter. Empowered Funds LLC purchased a new position in shares of Globe Life during the first quarter valued at $428,000. Finally, Focus Partners Wealth grew its holdings in shares of Globe Life by 8.3% during the first quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock valued at $1,127,000 after buying an additional 656 shares in the last quarter. 81.61% of the stock is owned by institutional investors and hedge funds.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.